Mood and Motivation in Parkinson's (2023)

In this webinar, Dr. Fidel Vila-Rodriguez, from the University of British Columbia Department of Psychiatry and Vancouver Coastal Health Research Institute, addressed the concept of Parkinson's disease as a brain network disorder. He also explored the distinction between adjustment disorders and depressive or anxiety disorders in Parkinson's, and delved into the effects of depression and anxiety medications for individuals with Parkinson's.

Dr. Vila-Rodriguez highlighted the relatively weak link between primary depressive or anxiety disorders and the later development of Parkinson's, contrasting it with Alzheimer's. He pointed out the complexity of diagnosing and treating depression and anxiety symptoms in Parkinson's. Notably, medications for these conditions exhibit delayed effects, making assessment of their effectiveness challenging.

Treatment options discussed for Parkinson's patients dealing with depression and anxiety included medications, non-medication alternatives like electroconvulsive therapy (ECT), counseling, and psychotherapy such as cognitive behavioural therapy (CBT). ECT emerged as particularly effective for severe depression and even showed promise in improving motor symptoms in Parkinson's patients.

Dr. Vila-Rodriguez stressed the importance of modifying treatment approaches based on symptom changes or lack of improvement, rather than altering them when symptoms remain stable. Additionally, non-medication treatments were considered valuable, particularly in the early stages of the illness.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**